Inflammatix Patents – Insights & Stats (Updated 2023)

Inflammatix has a total of 34 patents globally, out of which 5 have been granted. Of these 34 patents, more than 79% patents are active. United States of America is where Inflammatix has filed the maximum number of patents, followed by Europe and Canada. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Inflammatix.

Inflammatix was founded in the year 2016. The company’s line of business includes providing management consulting services.

Do read about some of the most popular patents of Inflammatix which have been covered by us in this article and also you can find Inflammatix patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Inflammatix patent portfolio.

How many patents does the founder and the CEO of Inflammatix have?

The founder Jonathan Romanowsky has 0 patent and Purvesh Khatri has 7 patents and CEO Tim Sweeney has 7 patents.

How many patents does Inflammatix have?

Inflammatix has a total of 34 patents globally. These patents belong to 9 unique patent families. Out of 34 patents, 27 patents are active.

How Many Patents did Inflammatix File Every Year?

Inflammatix Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantInflammatix Applications FiledInflammatix Patents Granted
20226
202161
20209
20197
20181
20131
20112
20081
20075

How many Inflammatix patents are Alive/Dead?

Inflammatix Patent Portfolio

How Many Patents did Inflammatix File in Different Countries?

Inflammatix Worldwide Patent Filing

Countries in which Inflammatix Filed Patents

CountryPatents
United States Of America10
Europe4
Canada3
Australia3
Japan2
United Kingdom1
Israel1
India1
Hong Kong (S.A.R.)1

Where are Research Centres of Inflammatix Patents Located?

The Research Centre for all the Inflammatix patents is the United States of America.

What Percentage of Inflammatix US Patent Applications were Granted?

Inflammatix (Excluding its subsidiaries) has filed 9 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 4 have been granted leading to a grant rate of 66.67%.

Below are the key stats of Inflammatix patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Inflammatix?

Law FirmTotal ApplicationsSuccess Rate
Schox7100.00%
Constellation Law Group20.00%

List of Inflammatix Patents

Inflammatix PatentsTitle
US11104946B2Dna Sequences Related To Diagnosis And Treatment Of Systemic Inflammatory Response Syndrome
US10001496B2Systems For Allergen Detection
US8617903B2Methods For Allergen Detection
US8068991B2Systems And Methods For Transmitting Pathogen Related Information And Responding
US20220399116A1Systems And Methods For Assessing A Bacterial Or Viral Status Of A Sample
US20210214779A1Assessing Host Rna Using Isothermal Amplification And Relative Abundance
US20210086172A1Fluidic Methods
US20200303078A1Systems And Methods For Deriving And Optimizing Classifiers From Multiple Datasets
EP4143343A1Determining Mortality Risk Of Subjects With Viral Infections
EP3942556A4Systems And Methods For Deriving And Optimizing Classifiers From Multiple Datasets
EP3853376A4Assessing Host Rna Using Isothermal Amplification And Relative Abundance
WO2023014598A3Isothermal Amplification-Based Diagnosis And Treatment Of Acute Infection
WO2023034111A1A Baseline Gene Expression-Based Prognostic For Anti-Tnf Alpha Therapy Response In Patients With Inflammatory Bowel Disease
WO2022235765A3Systems And Methods For Assessing A Bacterial Or Viral Status Of A Sample
WO2022240942A1Methods Of Diagnosis Of Respiratory Viral Infections
GB2460196BFluidic Methods
AU2021264555A1Determining Mortality Risk Of Subjects With Viral Infections
AU2020244763A1Systems And Methods For Deriving And Optimizing Classifiers From Multiple Datasets
AU2019345037A1Assessing Host Rna Using Isothermal Amplification And Relative Abundance
CA3177170A1Determining Mortality Risk Of Subjects With Viral Infections
CA3133639A1Systems And Methods For Deriving And Optimizing Classifiers From Multiple Datasets
CA3117201A1Assessing Host Rna Using Isothermal Amplification And Relative Abundance
JP2023525489ADetermining Mortality Risk In Subjects With Viral Infections
JP2022500060AAssessment Of Host Rna Using Isothermal Amplification And Relative Abundance
HK40057256AAssessing Host Rna Using Isothermal Amplification And Relative Abundance
IL286293ASystems And Methods For Deriving And Optimizing Classifiers From Multiple Datasets
IN202147045891ASystems And Methods For Deriving And Optimizing Classifiers From Multiple Datasets
US20080245740A1Fluidic Methods
US20080241910A1Devices For Pathogen Detection
EP3959338A1Dna Sequences Related To Diagnosis And Treatment Of Systemic Inflammatory Response Syndrome
WO2021222537A1Determining Mortality Risk Of Subjects With Viral Infections
WO2020219465A1Dna Sequences Related To Diagnosis And Treatment Of Systemic Inflammatory Response Syndrome
WO2020198068A1Systems And Methods For Deriving And Optimizing Classifiers From Multiple Datasets
WO2020061217A1Assessing Host Rna Using Isothermal Amplification And Relative Abundance

What are Inflammatix key innovation segments?

What Technologies are Covered by Inflammatix?

The chart below distributes patents filed by Inflammatix in different countries on the basis of the technology protected in patents. It also represents the markets where Inflammatix thinks it’s important to protect particular technology inventions.

R&D Focus: How has Inflammatix search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Inflammatix?

Table of Content

Insights you may find interesting

Related Articles

Pavegen Patents – Insights & Stats (Updated 2024)

Pavegen has a total of 36 patents globally, out of which 26 have been granted. Of these 36 patents, more than 47% patents are active. United Kingdom is where Pavegen has filed the maximum number of patents, followed by Europe (EPO) and Austria. Parallelly, United Kingdom seems to be the

Read More »

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.